Skip to content
Home/Companies/Healthcare/Fusion Antibodies Plc
Fusion Antibodies Plc

Fusion Antibodies Plc

Healthcare·UK·Exited 2017·Held 15yr
Entry
2002
Hold
15yr
Exit
2017

Who owns Fusion Antibodies Plc?

Fusion Antibodies Plc was owned by Qubis through QUBIS Ltd (1984 vintage) from 2002 to 2017, exited via IPO.

Hand-verified · updated 2026-04-21

Qubis
Investor
Qubis
QUBIS Ltd · 1984 · Evergreen

Key facts

HQUK
SectorHealthcare
Websitefusionantibodies-ir.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2017

More from QUBIS Ltd

Other portfolio companies in the same fund.

InnovaScope
Active
MedTechUK· 2025
LoyalBe
LoyalBe
Active
FintechUK· 2025
ReNewVax
Active
BiotechUK· 2025
Retinize
Active
SoftwareUK· 2025
StimOxyGen
StimOxyGen
Active
BiotechUK· 2025
Birota
Active
Business ServicesUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Fusion Antibodies Plc

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Fusion Antibodies Plc.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue